Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention
Phase of Trial: Phase II/III
Latest Information Update: 11 Aug 2016
At a glance
- Drugs Lorcaserin (Primary) ; Varenicline
- Indications Obesity; Smoking withdrawal
- Focus Therapeutic Use
- 09 Aug 2016 Status changed from not yet recruiting to recruiting.
- 03 May 2016 Planned initiation date changed from 1 Nov 2015 to 1 May 2016.
- 15 Oct 2015 Study phase changed from I/II to II/III, according to ClinicalTrials.gov record.